Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...

The idea for Amgen’s first foray into documentary film started with two numbers, according to Nerissa Gomes, general manager ...

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a ...

As biosimilars struggle to live up to their promise of cutting costs and improving access to biologic medicines for U.S.

Southwest Airlines is buckling up to join in on a long-running legal battle surrounding an alleged price-fixing scheme ...

The pharma began its outreach to the HS community well before securing Bimzelx’s approval in the indication. In the spring of ...

Novartis and a Swiss nonprofit have made history, scoring the world’s first approval for a medicine to treat babies who are ...

Achieve Life Sciences has signed up Omnicom to support the launch of nicotine dependence treatment cytisinicline, positioning ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and ...

It took several bids and months of back-and-forth negotiations, but CDMO Future Pak finally secured its long-sought buyout of HIV-focused drug maker Theratechnologies.  | Future Pak's most recent bid ...

Eight years after it was established partly by AstraZeneca, Dizal Pharmaceuticals has gained its first FDA approval, winning an accelerated nod for Zegfrovy (sunvozertinib) to become the only ...